Kymera
mad reduced to near in the skin | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
38 of 105
Related slides by other companies
Larimar Therapeutics
Investor Presentation
November 2023
completed phase multiple ascending dose study | Larimar Therapeutics
Arbutus Biopharma
Results
November 2022
demonstrates target engagement in cells in a mouse model | Arbutus Biopharma
Auto Trader Group
Results
November 2021
we saw reduced levels of retailer churn in the last months leading to a higher percentage of smaller sized forecourts in our customer base i | Auto Trader Group
NeuroSense Therapeutics
Investor Presentation
October 2024
phase a data demonstrated reduced and levels in als patients treated with | NeuroSense Therapeutics
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights